PHAXIAM Therapeutics S.A. Net Foreign Exchange Gain
PHAXIAM Therapeutics S.A. reported Net Foreign Exchange Gain of EUR 2.89 million for the 12-month period ending 2022-12-31, per its 20-F filed 2023-03-28.
Discontinued › Income Statement › Other Income
ifrs-full:NetForeignExchangeGain · last filed 2023-03-28
| Period end | Net Foreign Exchange Gain 6 month | Net Foreign Exchange Gain 12 month |
|---|---|---|
| 2022-12-31 | 2.89M EUR 20-F · filed 2023-03-28 | |
| 2021-12-31 | 3.57M EUR 20-F · filed 2022-04-27 | |
| 2021-06-30 | 1.44M EUR 6-K · filed 2021-09-20 | |
| 2020-06-30 | 542.00K EUR 6-K · filed 2021-09-20 | |
| 2019-12-31 | 781.00K EUR 20-F · filed 2022-04-27 | |
| 2018-12-31 | 3.99M EUR 20-F · filed 2021-03-08 |